{
  "meta": {
    "title": "9_Thyroid_Disorders_-_Management",
    "url": "https://brainandscalpel.vercel.app/9-thyroid-disorders-management-04607a8c.html",
    "scrapedAt": "2025-11-30T12:29:15.856Z"
  },
  "questions": [
    {
      "text": "A middle-aged woman who presented with tremors, palpitations, weight loss, and menstrual irregularities is diagnosed with Graves' disease. Which of the following statements would be correct with respect to her thyroid function test?",
      "choices": [
        {
          "id": 1,
          "text": "Low TSH levels"
        },
        {
          "id": 2,
          "text": "Low free T4 levels"
        },
        {
          "id": 3,
          "text": "Low  serum T3 levels"
        },
        {
          "id": 4,
          "text": "Radioactive Iodine Uptake (RAIU) at 24 hours below normal"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In <strong>Graves' disease</strong>, the level of <strong>serum TSH</strong> is <strong>low</strong>, <strong>free T4</strong> is <strong>high</strong> and <strong>serum T3</strong> is <strong>high</strong>. In patients with <strong>thyrotoxicosis</strong>, the <strong>radioactive iodine uptake</strong> (RAIU) at <strong>24 hours</strong> is <strong>characteristically elevated</strong>.</p>\n<p>Grave&rsquo;s disease is characterized by<strong> thyrotoxicosis</strong> caused by <strong>thyroid-stimulating immunoglobulins</strong> (TSIs) synthesized by lymphocytes in the thyroid gland, bone marrow, and lymph nodes. <strong>Thyroid peroxidase</strong> (TPO) and <strong>thyroglobulin</strong> (Tg) antibodies are also seen. This results in <strong>excess</strong> production of <strong>free T3</strong> and <strong>free T4</strong> levels and in turn <strong>reduces</strong> serum <strong>TSH</strong> levels.</p>\n<p><strong>RAIU</strong> is used to <strong>differentiate</strong> <strong>Grave&rsquo;s from other thyroid disorders</strong>, here there is diffuse high uptake. Measurement of TRab and TPOs is also done to confirm the diagnosis if the diagnosis clinically is unclear. </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/64adfd0224b446ae8efab0bb6d1b5b2ax1200x2321.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Radioiodine uptake of thyroid gland</h3><p>Radioactive iodine uptake (RAIU) scans are interpreted as follows:</p>\n<ul>\n<li><strong>High</strong> (or normal) radioiodine uptake indicates de-novo synthesis of the hormone. Therefore, there is increased hormone synthesis</li>\n<li><strong>Low</strong> (nearly absent) radioiodine uptake indicates:\n<ul>\n<li>Inflammation and destruction of thyroid tissue with release of the preformed hormone into the circulation</li>\n<li>Extrathyroidal source of thyroid hormone</li>\n</ul>\n</li>\n</ul>\n<p>Conditions with high and low RAIU are given below:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>High RAIU</strong></td>\n<td><strong>Low RAIU</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Graves&rsquo; disease</li>\n<li>Toxic multinodular goiter</li>\n<li>Toxic adenoma</li>\n<li>Thyroid cancer</li>\n<li>Hydatidiform mole</li>\n<li>TSH-secreting pituitary adenoma</li>\n</ul>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<ul>\n<li>Acute phase of Hashimoto&rsquo;s thyroiditis</li>\n<li>Drug-induced&mdash; iodine, amiodarone-induced thyroiditis</li>\n<li>Subacute/ Dequervain thyroiditis</li>\n<li>Radiation thyroiditis</li>\n<li>Metastatic follicular thyroid carcinoma</li>\n<li>Factitious (iatrogenic) thyrotoxicosis</li>\n<li>Struma ovarii (extrathyroid source)</li>\n<li>Hamburger thyrotoxicosis (exogenous source)</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/84debe461e9e4ef6a8de25fbe9c71e7fx1280x3027.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4524",
      "difficulty": "easy"
    },
    {
      "text": "What is the most common pattern of thyroid hormone levels in a patient with sick euthyroid syndrome?<div class='question-desc-html'><ol>\n<li>Decreased T3, Normal T4, Normal TSH</li>\n<li>Decreased T3 , Decreased T4, Normal TSH</li>\n<li>Normal T3, Normal T4, Increased TSH</li>\n<li>Normal T3, Increased T4, Normal TSH</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1"
        },
        {
          "id": 2,
          "text": "3"
        },
        {
          "id": 3,
          "text": "2"
        },
        {
          "id": 4,
          "text": "4"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The most common hormone pattern observed in <strong>sick euthyroid syndrome</strong> (SES) is a&nbsp;decrease in total and unbound T3 levels with normal levels of T4 and TSH. This pattern is&nbsp;called&nbsp;<strong>low T3 syndrome.</strong></p>\n<p>SES is caused by an acute severe illness in the absence of underlying thyroid disease. T4 to T3 conversion via <strong>peripheral deiodination </strong>is<strong> impaired&nbsp;</strong>leading to a fall in T3 corresponding to the severity of illness.&nbsp;There is an adaptive <strong>increase</strong> in the level of<strong> reverse T3</strong> (rT3).&nbsp;</p>\n<p>In very sick patients, there can be a dramatic fall in both total T4 and T3 levels. This pattern is called <strong>low T4 syndrome</strong> and&nbsp;is associated with a <strong>poor prognosis.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6626",
      "difficulty": "medium"
    },
    {
      "text": "On thyroid function test analysis, TSH value was much higher than normal with a low free T4. What is the diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Subclinical hypothyroidism"
        },
        {
          "id": 2,
          "text": "Hyperthyroidism"
        },
        {
          "id": 3,
          "text": "Secondary hypothyroidism"
        },
        {
          "id": 4,
          "text": "Primary hypothyroidism"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>An <strong>elevated TSH</strong> value with <strong>low free T4</strong> is suggestive of <strong>primary hypothyroidism</strong> (Option D).</p>\n<p>Option A: In <strong>subclinical hypothyroidism</strong>, free <strong>T4</strong> levels remain <strong>normal</strong> despite <strong>elevated TSH</strong>.</p>\n<p>Option B: <strong>TSH</strong> is <strong>low</strong> in <strong>hyperthyroidism</strong>.</p>\n<p>Option C: The diagnosis of <strong>secondary hypothyroidism</strong> is made along with a <strong>deficiency</strong> of <strong>other</strong> <strong>pituitary hormones</strong>. TSH levels may be low, normal, or slightly increased. The elevation in TSH levels can be attributed to the secretion of immunoreactive but biologically inactive forms of TSH. To <strong>confirm</strong> the <strong>diagnosis</strong>, it is essential to detect a <strong>low</strong> level of <strong>unbound T4</strong>.</p><p>The diagnostic approach to hypothyroidism is given in the flowchart below:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/98ba447d91a2415cb2ccbe628103d66ax1280x2249.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Causes of Hypothyroidism</h3><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Primary </strong></p>\n<p>(Low T3, T4 &rarr; Raised TSH levels)</p>\n</td>\n<td>\n<p><strong>Secondary</strong></p>\n<p><strong> </strong>(Low TSH levels &rarr; Low T3, T4)</p>\n</td>\n<td>\n<p><strong>Tertiary</strong></p>\n<p><strong> </strong>(Low TRH &rarr; Low TSH &rarr; Low T3,T4)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Hashimoto&rsquo;s thyroiditis</strong></p>\n<p>RAI therapy for Grave&rsquo;s disease</p>\n<p>Post thyroidectomy</p>\n<p>Excessive iodine intake - Wolff Chiakoff effect</p>\n<p>Subacute thyroiditis</p>\n<p>Medications: Antithyroid drugs, lithium</p>\n<p>Iodine deficiency, dyshormonogenesis</p>\n</td>\n<td>\n<p><strong>Pituitary tumour</strong></p>\n<p>Pituitary resection or ablation</p>\n</td>\n<td>\n<p><strong>Hypothalamic insufficiency</strong></p>\n<p>Resistance to thyroid hormone</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1164",
      "difficulty": "medium"
    },
    {
      "text": "The radio-iodine uptake scan of a patient evaluated for swelling of the thyroid is shown below. Which of the following is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Hypersecreting adenoma"
        },
        {
          "id": 2,
          "text": "Papillary Carcinoma thyroid"
        },
        {
          "id": 3,
          "text": "Graves disease"
        },
        {
          "id": 4,
          "text": "Lateral aberrant thyroid"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given image showing localized overactivity (increased uptake) in the left lobe of the thyroid i.e., <strong>hot nodule</strong>, with suppression of the remainder of the gland, is suggestive of a <strong>hypersecreting adenoma</strong>.</p>\n<p>Other options: </p>\n<p>Option B: The likelihood of <strong>malignancies</strong> like papillary Carcinoma thyroid is <strong>low</strong> (5%) in the case of a <strong>hot nodule</strong>.</p>\n<p>Option C: <strong>Graves disease</strong> shows <strong>diffusely increased uptake</strong> on a thyroid scan.</p>\n<p>Option D: <strong>Lateral aberrant thyroid</strong> presents with swelling of <strong>cervical lymph nodes</strong> and not thyroid. It is due to<strong> skip metastasis</strong> from<strong> papillary thyroid carcinoma </strong>to the ipsilateral cervical lymph nodes.</p>\n<p>The thyroid scan appearance in different conditions is shown in the image below:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/446147cae6bd406294d261351cfe7cdfx1280x2916.JPEG\" alt=\"Explanation Image\"><p><strong>Diagnostic isotope</strong> studies, such as 99mTc-pertechnetate and iodine-123, are becoming less common in thyroid imaging because some <strong>warm swellings (5%)</strong> which are actually <strong>malignant</strong> could be <strong>mistaken as benign</strong>. Isotope scanning is most valuable when assessing a <strong>hyperthyroid patient</strong> presenting with a nodule or nodularity in the thyroid. It helps to identify <strong>overactivity in the gland</strong>, which can <strong>differentiate</strong> between a <strong>toxic nodule</strong> that suppresses the rest of the gland and a <strong>toxic multinodular goitre</strong> with multiple areas of increased uptake.</p><hr><h3>Related Pearl: Radioiodine uptake of thyroid gland</h3><p>Radioactive iodine uptake (RAIU) scans are interpreted as follows:</p>\n<ul>\n<li><strong>High</strong> (or normal) radioiodine uptake indicates de-novo synthesis of the hormone. Therefore, there is increased hormone synthesis</li>\n<li><strong>Low</strong> (nearly absent) radioiodine uptake indicates:\n<ul>\n<li>Inflammation and destruction of thyroid tissue with release of the preformed hormone into the circulation</li>\n<li>Extrathyroidal source of thyroid hormone</li>\n</ul>\n</li>\n</ul>\n<p>Conditions with high and low RAIU are given below:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>High RAIU</strong></td>\n<td><strong>Low RAIU</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Graves&rsquo; disease</li>\n<li>Toxic multinodular goiter</li>\n<li>Toxic adenoma</li>\n<li>Thyroid cancer</li>\n<li>Hydatidiform mole</li>\n<li>TSH-secreting pituitary adenoma</li>\n</ul>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<ul>\n<li>Acute phase of Hashimoto&rsquo;s thyroiditis</li>\n<li>Drug-induced&mdash; iodine, amiodarone-induced thyroiditis</li>\n<li>Subacute/ Dequervain thyroiditis</li>\n<li>Radiation thyroiditis</li>\n<li>Metastatic follicular thyroid carcinoma</li>\n<li>Factitious (iatrogenic) thyrotoxicosis</li>\n<li>Struma ovarii (extrathyroid source)</li>\n<li>Hamburger thyrotoxicosis (exogenous source)</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/84debe461e9e4ef6a8de25fbe9c71e7fx1280x3027.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/d2d0ede29d4d42ce98e2ed30593c890f.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1541",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following drugs can cause the condition shown below?",
      "choices": [
        {
          "id": 1,
          "text": "Methimazole"
        },
        {
          "id": 2,
          "text": "Propylthiouracil"
        },
        {
          "id": 3,
          "text": "Radioactive iodine"
        },
        {
          "id": 4,
          "text": "Levothyroxine"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given image shows&nbsp;the absence of scalp hair and skin, along with calvarial defects(skull bone defects), suggestive of <strong>aplasia cutis congenita</strong>. This is&nbsp;commonly associated with <strong>carbimazole </strong>and<strong> methimazole</strong>.</p>\n<p>These drugs can also cause other defects such as:</p>\n<ul>\n<li>Choanal atresia&nbsp;</li>\n<li>Tracheoesophageal fistula</li>\n<li>Fetal goiter</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/28da72d5a99d4d2197e4cff33f66c680.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6621",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following patients cannot undergo radioiodine therapy?",
      "choices": [
        {
          "id": 1,
          "text": "Patients with renal disease"
        },
        {
          "id": 2,
          "text": "Patients with cardiac disease"
        },
        {
          "id": 3,
          "text": "Lactating mother"
        },
        {
          "id": 4,
          "text": "Patients with severe ophthalmopathy"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Lactating mothers cannot undergo radioiodine therapy.&nbsp;<strong>Pregnancy</strong> and <strong>breastfeeding</strong>&nbsp;are <strong>absolute contraindications</strong>&nbsp;of <strong>radioiodine therapy</strong>. Patients can safely conceive<strong> 6 months after</strong> undergoing radioiodine treatment.</p>\n<p>Radioiodine therapy in patients with <strong>severe ophthalmopathy</strong> can be given with <strong>caution</strong> along with prednisone to prevent exacerbation of ophthalmopathy.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6619",
      "difficulty": "easy"
    },
    {
      "text": "A 25-year-old woman presents with palpitations. She informs you that a urine pregnancy test done one week ago was positive. Her investigations reveal hyperthyroidism. Which of the following antithyroid drugs can be prescribed for her?",
      "choices": [
        {
          "id": 1,
          "text": "Propylthiouracil"
        },
        {
          "id": 2,
          "text": "Methimazole"
        },
        {
          "id": 3,
          "text": "Carbimazole"
        },
        {
          "id": 4,
          "text": "Propranolol"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The patient in the given clinical scenario is in the <strong>1st trimester</strong> of pregnancy. <strong>Propylthiouracil</strong> is used in the 1st trimester of gestation because it has lower teratogenic effects than carbimazole.</p>\n<p><strong>Carbimazole</strong> and <strong>methimazole</strong> are associated with teratogenic effects such as</p>\n<ul>\n<li>Aplasia cutis congenita&nbsp;&nbsp;</li>\n<li>Choanal atresia</li>\n<li>Treacheosopageal fistula</li>\n<li>Fetal goiter</li>\n</ul>\n<p>However, propylthiouracil use is limited to the first trimester due to the <strong>risk of hepatotoxicity</strong>. It is replaced with carbimazole or methimazole in the 2nd and 3rd trimesters of the pregnancy.</p>\n<p>The lowest effective antithyroid drug dose&nbsp;should be used throughout gestation. This is to <strong>maintain</strong> the <strong>maternal </strong>serum-<strong>free</strong> <strong>T4 level</strong> in&nbsp;the <strong>upper limit</strong> of the <strong>non-pregnant normal</strong> reference range.</p><hr><h3>Related Pearl: Drug of choice for hyperthyroidism/thyrotoxicosis in pregnancy</h3><p>In the 1st trimester: <strong>Propylthiouracil</strong></p>\n<p>In the 2nd and 3rd trimester: <strong>Methimazole</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6620",
      "difficulty": "easy"
    },
    {
      "text": "A patient undergoing radioactive iodine therapy for a non-toxic multinodular goitre later develops altered sensorium, fever, and vomiting. What is the anti-thyroid drug of choice in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Propranolol"
        },
        {
          "id": 2,
          "text": "Iodide"
        },
        {
          "id": 3,
          "text": "Propylthiouracil"
        },
        {
          "id": 4,
          "text": "Methimazole"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given scenario is suggestive of <strong>thyroid storm</strong> and&nbsp;<strong>propylthiouracil</strong> is the drug of choice in this patient. This is due to its <strong>inhibitory</strong> action on peripheral <strong>T4 &rarr; T3 conversion</strong>.</p>\n<p>PTU is administered in large doses (500&ndash;1000 mg loading dose and 250 mg every 4h) administered orally / via nasogastric tube / per rectum.&nbsp;</p>\n<p><strong>Propranolol</strong> is also given to <strong>reduce</strong> symptoms like tachycardia and other <strong>adrenergic manifestations</strong>.</p><hr><h3>Related Pearl: Thyroid storm / Thyrotoxic crisis:</h3><p>It is an emergency caused by an acute exacerbation of hyperthyroidism.&nbsp;</p>\n<p>Precipitating factors:</p>\n<ul>\n<li>When a thyrotoxic patient has been<strong> inadequately prepared for thyroidectomy</strong></li>\n<li>Abrupt cessation of antithyroid medications</li>\n<li>Stress\n<ul>\n<li>Infection</li>\n<li>Thyroid or non-thyroid surgery</li>\n<li>Trauma in patients with untreated thyrotoxicosis</li>\n</ul>\n</li>\n<li>Acute iodine load\n<ul>\n<li>Amiodarone administration&nbsp;</li>\n<li>Exposure to iodinated contrast agents</li>\n<li>Following RAI therapy</li>\n</ul>\n</li>\n</ul>\n<p>Clinical features:</p>\n<ul>\n<li>Fever</li>\n<li>Tachycardia</li>\n<li>Altered mentation (delirium, psychosis, coma)</li>\n<li>GI symptoms (nausea, vomiting, diarrhoea)</li>\n<li><strong>Atrial fibrillation</strong> and <strong>cardiac failure</strong> - most common causes of death</li>\n</ul>\n<p>Treatment of thyroid storm:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Treatment modality</strong></td>\n<td><strong>Effect</strong></td>\n</tr>\n<tr>\n<td>IV Fluids, ice packs</td>\n<td>Rehydration and external cooling</td>\n</tr>\n<tr>\n<td><strong>Propylthiouracil</strong><br /><strong>(DOC)</strong></td>\n<td>\n<p>Reduces peripheral T4 to T3 conversion</p>\n</td>\n</tr>\n<tr>\n<td>Propranolol</td>\n<td>\n<p>Block adrenergic effects</p>\n<p>Reduces peripheral T4 to T3 conversion</p>\n</td>\n</tr>\n<tr>\n<td>Corticosteroids</td>\n<td>\n<p>Inhibits the release of thyroid hormone from the gland</p>\n<p>Reduces peripheral T4 to T3 conversion</p>\n</td>\n</tr>\n<tr>\n<td>Lugol&rsquo;s iodine/ sodium ipodate</td>\n<td>Inhibits the release of thyroid hormone from the gland</td>\n</tr>\n<tr>\n<td>Digoxin</td>\n<td>Controls the associated atrial fibrillation</td>\n</tr>\n<tr>\n<td>Diuretics and administration of oxygen</td>\n<td>\n<p>To manage cardiac failure</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6622",
      "difficulty": "medium"
    },
    {
      "text": "A patient presents with a diffusely enlarged thyroid gland. However, she has no features of hyperthyroidism. Which of the following statements about her condition is false?",
      "choices": [
        {
          "id": 1,
          "text": "It is also referred to as simple goitre or colloid goitre"
        },
        {
          "id": 2,
          "text": "Most commonly caused by iodine deficiency"
        },
        {
          "id": 3,
          "text": "Surgery is commonly indicated"
        },
        {
          "id": 4,
          "text": "Thyroid function tests should be performed in all patients with goiter"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given scenario is suggestive of a&nbsp;<strong>non-toxic diffuse goitre</strong>. <strong>Surgery</strong> is <strong>rarely indicated</strong> in this condition, except for cosmetic reasons, tracheal compression or obstruction of the thoracic inlet.</p>\n<p>It is sometimes called&nbsp;<strong>simple goitre </strong>-&nbsp;because of the absence of nodules, and <strong>colloid goitre </strong>-<strong>&nbsp;</strong>because of the presence of uniform follicles that are filled with colloid. It is most commonly caused by<strong> iodine deficiency</strong> and is often termed&nbsp;<strong>endemic goitre</strong>.</p>\n<p>Most diffuse goitres are <strong>benign</strong> and <strong>asymptomatic</strong>. Examination reveals a symmetrically enlarged, non-tender, generally soft gland without palpable nodules. <strong>TFTs </strong>should be performed in all patients to <strong>exclude thyrotoxicosis or hypothyroidism</strong>.</p>\n<p>If markedly enlarged, it can cause tracheal/oesophagal<strong> compression</strong>.</p>\n<p><strong>Substernal goitre</strong> may obstruct the thoracic inlet leading to a positive<strong> Pemberton&rsquo;s sign</strong>&nbsp;i.e., facial congestion on bilateral arm elevation due to venous occlusion.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6629",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements about silent thyroiditis is true?",
      "choices": [
        {
          "id": 1,
          "text": "Painful thyroiditis"
        },
        {
          "id": 2,
          "text": "Glucocorticoids are not indicated for treatment"
        },
        {
          "id": 3,
          "text": "It is not associated with thyrotoxicosis"
        },
        {
          "id": 4,
          "text": "It is not associated with hypothyroidism"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Glucocorticoid treatment is not indicated in silent thyroiditis.</p>\n<p>The condition is called <strong>silent thyroiditis</strong>, as it is <strong>painless</strong>. When it occurs 3-6 months after pregnancy, it is termed <strong>postpartum thyroiditis</strong>. The condition is observed in up to 5% of women and it is 3 times more common in women with Type 1 diabetes mellitus.</p>\n<p>Typically, patients experience a <strong>brief</strong> phase of <strong>thyrotoxicosis</strong> lasting 2-4 weeks, followed by<strong> hypothyroidism</strong> for 4-12 weeks, and then <strong>clinical resolution.</strong> Often, only one phase is apparent.</p>\n<p>In addition to painless goitre, silent thyroiditis can be distinguished from subacute thyroiditis by a <strong>normal ESR </strong>value and the presence of <strong>TPO antibodies</strong>.</p>\n<p>Severe <strong>thyrotoxic symptoms</strong> can be managed with a brief course of <strong>propranolol</strong>, a 20&ndash;40 mg dose administered three or four times daily.</p>\n<p><strong>Thyroxine replacement</strong> may be needed for treating the <strong>hypothyroid phase</strong> but should be <strong>withdrawn</strong> after 6&ndash;9 months, to enable patient recovery.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6625",
      "difficulty": "hard"
    },
    {
      "text": "A middle-aged woman with fatigue, depression and weight gain was found to have hypothyroidism. Which of the following statements is false about the treatment of her condition?",
      "choices": [
        {
          "id": 1,
          "text": "The replacement dose of thyroid is 1.6 μg/kg body weight"
        },
        {
          "id": 2,
          "text": "Complete relief from symptoms might occur within 3-6 months after initiation of treatment"
        },
        {
          "id": 3,
          "text": "TSH responses should be determined 2 months following the initiation of treatment or change in dose"
        },
        {
          "id": 4,
          "text": "Once TSH level is stable, TSH measurement is recommended at annual intervals"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The clinical effects of levothyroxine replacement are slow to appear. Patients may not experience full relief from symptoms until <strong>3&ndash;6 months after normal TSH</strong> levels are <strong>restored</strong>.</p>\n<p>If there is no residual function, the&nbsp;<strong>daily</strong> <strong>replacement dose</strong> of levothyroxine is usually <strong>1.6 &mu;g/kg body weight</strong> (typically 100&ndash;150 &mu;g), ideally taken at least 30 minutes before breakfast.</p>\n<p><strong>TSH responses </strong>are<strong> gradual</strong> and should be determined <strong>2 months</strong> following the initiation of treatment or change in dose.&nbsp;Once the full replacement is achieved and TSH levels are stable, TSH measurement is recommended at <strong>annual intervals.</strong></p>\n<p>In patients who have developed hypothyroidism following treatment of Graves' disease, lower doses are needed for replacement. This is because there is often underlying autonomous function, necessitating lower replacement doses (typically 75&ndash;125 &mu;g/d).</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6591",
      "difficulty": "medium"
    },
    {
      "text": "A 24-year-old primigravida at 10 weeks of gestational age presents to your OPD. She is on oral levothyroxine supplementation for hypothyroidism. What is the target TSH level to be maintained in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "<2.5 mIu/L"
        },
        {
          "id": 2,
          "text": "<3.0 mIu/L"
        },
        {
          "id": 3,
          "text": "<3.5 mIu/L"
        },
        {
          "id": 4,
          "text": "<4.0 mIu/L"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The <strong>target TSH</strong> level to be maintained in the <strong>first trimester</strong> of pregnancy is <strong>&lt;2.5 mIU/L</strong>.&nbsp;For <strong>second and third trimester</strong>&nbsp;the target is<strong>&nbsp;&lt;3.0 mIU/L</strong>.</p>\n<p>Thyroid function must be evaluated by <strong>testing</strong> for <strong>TSH</strong> levels <strong>every 4 weeks</strong> in the <strong>first trimester</strong> and less frequently after 20 weeks. The <strong>levothyroxine </strong>dose may be <strong>increased</strong> <strong>by</strong> <strong>50%</strong> during <strong>pregnancy.</strong> Following delivery, doses of thyroxine are usually restored to that of pre-pregnancy levels.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6589",
      "difficulty": "medium"
    },
    {
      "text": "An elderly woman with hypothyroidism presents to the ER with decreased consciousness, hypothermia, sinus bradycardia, and hypotension. Her family members reveal that she has not been taking her thyroid medications recently. Investigations reveal elevated TSH levels and reduced T3 and T4 levels. All of the following can be used in the treatment except:",
      "choices": [
        {
          "id": 1,
          "text": "IV levothyroxine"
        },
        {
          "id": 2,
          "text": "Liothyronine (T3)"
        },
        {
          "id": 3,
          "text": "Parenteral steroids"
        },
        {
          "id": 4,
          "text": "Hypotonic IV fluids"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given scenario is suggestive of <strong>myxedema coma</strong>. Hypotonic IV fluids are avoided in the course of treatment of this condition. However, <strong>hypertonic saline</strong> is used.</p>\n<p>Hypotonic fluids may exacerbate water retention and dilutional hyponatremia&nbsp;secondary to impaired renal perfusion and inappropriate vasopressin.</p>\n<p>Treatment of myxedema coma includes:</p>\n<ul>\n<li><strong>Levothyroxine (T4)</strong> can be administered as a&nbsp;<strong>single IV bolus </strong>of 500 &mu;g. Although further doses are strictly not required, it is continued at 50-100 &mu;g/day.</li>\n<li>An <strong>alternative</strong>&nbsp;mode of treatment is the <strong>IV</strong><strong>&nbsp;administration of&nbsp;liothyronine (T3) </strong>or via NG tubes with doses ranging from 10-25 &mu;g every 8-12 hours in case T4 to T3 conversion in myxedema is impaired.</li>\n<li><strong>Parenteral hydrocortisone</strong> should be administered to treat a condition of&nbsp;impaired adrenal reserve in profound hypothyroidism.</li>\n<li><strong>Hypertonic saline</strong> or <strong>IV glucose</strong> may be recommended for treatment.</li>\n<li><strong>External warming</strong> is indicated only if the temperature is less than&nbsp;30<sup>o</sup>C.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6593",
      "difficulty": "medium"
    }
  ]
}